Topical Oxygen Therapy Market Research, 2031
The global topical oxygen therapy market size was $19,889.74 thousand in 2021, and is projected to reach $27,721.76 thousand by 2031, growing at a CAGR of 3.4% from 2022 to 2031. Topical oxygen therapy (TOT) is the administration of oxygen applied topically over injured tissue by either continuous diffusion or pressurized systems. There are dressings, gels, hemoglobin sprays, mechanical devices specifically indicated for topical oxygen therapy. Since oxygen is applied directly to the wound site and there is no additional inspiration of oxygen, there are no fatal effects in comparison to HBOT. Topical oxygen therapy is U.S. FDA approved for venous insufficiency, postsurgical infections, gangrenous lesions, skin grafts, burns, frostbite, and amputations.it is also used during the treatment of arterial ulcers, chronic wounds, diabetic neuropathic foot ulcers, pressure ulcers and stages 3 and 4 of venous ulcers. It is applied in the comfort of a patient’s home and consists of a sterile, single-use, disposable, gas-impermeable chamber with adhesive edges applied as a boot or bag administered around the affected extremity or wound.
The advantage of this system is that it costs low and does not involve systemic oxygen, which can place a patient at risk for oxygen toxicity. Moreover, it is a non-invasive adjunctive multi-modality therapy that applies cyclical oxygen pressure to the wound site within a sealed humidified environment. Available in both reusable and single-patient use versions. Topically applied oxygen is applied either intermittently, following a treatment regimen similar to HBO (90 minutes a day, 3 to 5 days a week), or continuously (24 hours a day, 7 days a week).Intermittent topical oxygen therapy is used to treat an area directly surrounding a patient’s wound using concentrated (~93%) oxygen at pressures slightly above atmospheric, typically less than 1.1 atm, which is supplied by a high-flow oxygen concentrator and applied using a bag or chamber sealed around the wound. Continuously applied topical oxygen therapy is applied directly to the wound, using pure (>99%), humidified oxygen supplied by a small, wearable electrochemical oxygen generator.
Topically applied oxygen comes in various forms, ranging from large systems consisting of high flow oxygen concentrators bundled with hard-walled chambers to small, wearable oxygen generators with oxygen delivery systems. One of the advantages of all these systems is that they all can be placed/used in most environments, including at home. These systems apply oxygen directly to the wound and can be used adjunctively to many other therapies, including but not limited to moist wound therapy dressings and grafting materials. There are basically three different classes of gaseous topical oxygen delivery including topical oxygen (TO), transcutaneous oxygen therapy (TCOT) and continuous diffusion of oxygen (CDO). .
The demand for topical oxygen therapy is anticipated to increase globally during topical oxygen therapy market forecast, owing to increase in incidence of chronic wounds, surge in patient pool of diabetics, and high incidence of wound site infections. Moreover, patients are eager to know more about the topical oxygen therapy treatment process, the growth in global recognition of topical oxygen therapy, increased number of surgical procedures, and technological advancement in advanced wound care that further drive the growth of this market. However, lack of awareness in developing countries is anticipated to hamper the market growth. Conversely, introduction of topical oxygen therapy in emerging economies is expected to offer lucrative topical oxygen therapy market opportunity for the key players in the market.
The topical oxygen therapy market is segmented on the basis of application, end user, and region. On the basis of application, the market is classified into chronic wound and acute wound. On the basis of end user, market is divided into hospitals, clinics, homecare, and post-acute care settings. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By application, the chronic wound segment had dominant topical oxygen therapy market share in 2021, and is anticipated to continue this trend during the forecast period, owing to growth in prevalence of chronic wound, specifically in geriatric population suffering from diabetes and wound site infection. On the other side, the demand for acute wound is projected to exhibit the fastest topical oxygen therapy market growth during the forecast period, owing to the rise in surgical wounds. In addition, R&D in acute wound care products, surge in funding in wound care research, and growth in awareness programs for wound care are anticipated to contribute toward the growth of the topical oxygen therapy industry
By end user, the homecare segment held largest topical oxygen therapy market share in 2021, and is anticipated to continue this trend during the forecast period, owing to increased costs of medicines & devices, rise in capital costs, and an increase in the numbers of people with chronic conditions require primary and secondary healthcare support.
By region, North America dominated the market in 2021, accounting for the largest topical oxygen therapy market size, and is anticipated to maintain this trend during the forecast period. Well-established healthcare system, increase in number of geriatric patients, supportive reimbursement policies in healthcare system, and surge in number of healthcare facilities offering topical oxygen therapy propel the market growth.
The major companies profiled in topical oxygen therapy industry include AOTI, Inc., Inotec AMD Ltd., GWR Inc, OxyBand Technologies, EO2 Concepts, Mölnlycke Health Care AB, OGENIX and RashEndZ Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the topical oxygen therapy market analysis from 2021 to 2031 to identify the prevailing topical oxygen therapy market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the topical oxygen therapy market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global topical oxygen therapy market trends, key players, market segments, application areas, and market growth strategies.
Topical Oxygen Therapy Market Report Highlights
By End User
Key Market Players
RASHENDZ INC., MöLNLYCKE HEALTH CARE AB, OXYBAND TECHNOLOGIES, INOTEC AMD LTD., OGENIX, EO2 CONCEPTS, AOTI, INC., GWR INC.
Topical oxygen therapy (TOT) can be defined as the administration of oxygen applied topically over injured tissue by either continuous diffusion or pressurized systems. However, there are dressings, gels, and hemoglobin sprays that can provide for oxygen release when applied to wounds. Moreover, it can be considered as an adjunctive modality for the treatment and management of wound care.
According to the CXOs of key companies, the adoption of topical oxygen therapy is anticipated to increase in the future, owing to surge in government support for topical oxygen therapy and technological developments in advance wound care products. Moreover, the supply of topical oxygen therapy devices is anticipated to become streamlined and effective, owing to improved cGMP guideline from the FDA. Manufacturers are expected to gain additional income by diversifying their product offering to cater to the needs of new markets. Lack of awareness is projected to remain a source of concern and limit the rate of adoption of these modules; however, the availability of funds and grants from the government is expected to drive growth of this market.
As per the perspective of CXOs, North America is expected to dominate the topical oxygen therapy market during the forecast period, followed by Europe. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period.